Anti-PD-1 Immunotherapy and Radiotherapy for Stage IV Intrahepatic Cholangiocarcinoma: A Case Report

Due to the unsatisfactory robustness of current predictive biomarkers in many cases, application of immunotherapy in advanced cancers with limited treatment options, such as stage IV intrahepatic cholangiocarcinoma (ICC), was quite common. Hence, strategies to enhance the therapeutic effect of immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ze-Long, Liu, Xin, Peng, Hong, Peng, Zhen-Wei, Long, Jian-Ting, Tang, Di, Peng, Sui, Bao, Yong, Kuang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485089/
https://www.ncbi.nlm.nih.gov/pubmed/32984358
http://dx.doi.org/10.3389/fmed.2020.00368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485089/
https://www.ncbi.nlm.nih.gov/pubmed/32984358
http://dx.doi.org/10.3389/fmed.2020.00368

Ejemplares similares